News & Updates

Pegylated interferon alpha-2b: A good bet for treating COVID-19?

31 Aug 2021 by

Pegylated interferon alpha-2b (PEG IFN) appears to be beneficial in the treatment of patients with moderate COVID-19 infection, with the results of a phase III trial showing that its use has facilitated clinical status improvement, early viral clearance, and weaning off oxygen.

Pegylated interferon alpha-2b: A good bet for treating COVID-19?

31 Aug 2021

Telmisartan protective against dementia in hypertensive, T2D patients?

31 Aug 2021 by

Use of the angiotensin receptor blocker (ARB) telmisartan in an East Asian population with hypertension and type 2 diabetes (T2D) was associated with a lower risk of dementia and any ischaemic stroke events compared with other ARBs, a nationwide cohort study has shown.

Telmisartan protective against dementia in hypertensive, T2D patients?

31 Aug 2021

Atogepant reduces migraine days in patients with episodic migraine

31 Aug 2021 by

Treatment with atogepant significantly reduces the number of migraine days compared with placebo in patients with episodic migraine, according to the ADVANCE* study.

Atogepant reduces migraine days in patients with episodic migraine

31 Aug 2021

8 hours of sitting time per day pose long-term risk of stroke

30 Aug 2021

Among individuals with low physical activity, excess leisure sedentary time of at least 8 hours daily translates to a heightened long-term stroke risk, as suggested in a study.

8 hours of sitting time per day pose long-term risk of stroke

30 Aug 2021

Neuroprosthesis may restore ability to communicate in paralyzed persons with anarthria

30 Aug 2021 by

Using deep-learning and natural-language models, words and sentences were directly decoded from cortical activity during attempted speech in an individual with anarthria (ie, inability to articulate speech) and spastic quadriparesis.

Neuroprosthesis may restore ability to communicate in paralyzed persons with anarthria

30 Aug 2021

Studies highlight potential link between COVID-19 and cognitive impairment

27 Aug 2021 by

Several studies presented at AAIC 2021 have suggested a possible link between COVID-19 and cognitive impairment.

Studies highlight potential link between COVID-19 and cognitive impairment

27 Aug 2021

Functional near-infrared spectroscopy matches fMRI at detecting task-related brain signals

27 Aug 2021

Whole-head functional near-infrared spectroscopy (fNIRS) can perform comparably to functional magnetic resonance imaging (fMRI) at detecting task-related cortical haemodynamic changes across the lateral cortex, a recent study has found.

Functional near-infrared spectroscopy matches fMRI at detecting task-related brain signals

27 Aug 2021

Short sleep may be early warning sign of Alzheimer’s disease

25 Aug 2021 by

Sleep time, estimated by an actigraphy watch, correlates with cerebrospinal fluid (CSF) levels of t-tau and p-tau, suggesting its potential role as an early marker of Alzheimer’s disease (AD), according to a recent study.

Short sleep may be early warning sign of Alzheimer’s disease

25 Aug 2021

Low zinc levels a potential risk factor for stroke

25 Aug 2021

There appears to be an inverse relationship between serum zinc concentrations and the incidence of ischaemic stroke, especially among women, a study has found.

Low zinc levels a potential risk factor for stroke

25 Aug 2021

High-dose aducanumab delays clinical decline across multiple domains in early AD

25 Aug 2021 by

Treatment with high-dose aducanumab shows less clinical decline across individual items or domains of cognition, function, and behaviour compared with placebo in patients with early symptomatic Alzheimer’s disease (AD), according to the EMERGE* study presented at AAIC 2021.

High-dose aducanumab delays clinical decline across multiple domains in early AD

25 Aug 2021

News & Updates

Filter by Specialty:

Specialty:

Pegylated interferon alpha-2b: A good bet for treating COVID-19?

Pegylated interferon alpha-2b: A good bet for treating COVID-19?

Telmisartan protective against dementia in hypertensive, T2D patients?

Telmisartan protective against dementia in hypertensive, T2D patients?

Atogepant reduces migraine days in patients with episodic migraine

Atogepant reduces migraine days in patients with episodic migraine

8 hours of sitting time per day pose long-term risk of stroke

8 hours of sitting time per day pose long-term risk of stroke

Neuroprosthesis may restore ability to communicate in paralyzed persons with anarthria

Neuroprosthesis may restore ability to communicate in paralyzed persons with anarthria

Studies highlight potential link between COVID-19 and cognitive impairment

Studies highlight potential link between COVID-19 and cognitive impairment

Functional near-infrared spectroscopy matches fMRI at detecting task-related brain signals

Functional near-infrared spectroscopy matches fMRI at detecting task-related brain signals

Short sleep may be early warning sign of Alzheimer’s disease

Short sleep may be early warning sign of Alzheimer’s disease

Low zinc levels a potential risk factor for stroke

Low zinc levels a potential risk factor for stroke

High-dose aducanumab delays clinical decline across multiple domains in early AD

High-dose aducanumab delays clinical decline across multiple domains in early AD